ASIA FINNEGAN: Open Payments
NPI 1083361059 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,330 in 64 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,327 · 2025 $2,330
Food & beverage: $2,131Education: $199
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $458 |
| Janssen Biotech, Inc. | 11 | $454 |
| ABBVIE INC. | 16 | $400 |
| UCB, Inc. | 10 | $309 |
| Regeneron Healthcare Solutions, Inc. | 2 | $229 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $114 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Journey Medical Corporation | 1 | $77 |
| Arcutis Biotherapeutics, Inc. | 5 | $77 |
| Lilly USA, LLC | 3 | $62 |
Products named: TREMFYA, SKYRIZI, RINVOQ, COSENTYX, Winlevi, DUPIXENT, Bimzelx, Zoryve.
Industry payments across PA — which companies pay providers there.
